Experimental study on the therapeutic effect of brucine nanoparticles on hepatocellular carcinoma
10.3760/cma.j.issn.1007-8118.2011.12.015
- VernacularTitle:马钱子碱纳米微粒抗肝细胞癌作用的实验研究
- Author:
Jianmin QIN
;
Zhongqiu SA
;
Xiajun XU
;
Lin YANG
;
Xia SHENG
;
Min ZHANG
;
Qi LI
;
Peihao YIN
;
Kepan GAO
;
Qinghua CHEN
- Publication Type:Journal Article
- Keywords:
Brucine;
Nanoparticle;
Hepatocellular carcinoma
- From:
Chinese Journal of Hepatobiliary Surgery
2011;17(12):1005-1008
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the therapeutic effect of brucine nanoparticles on hepatocellular carcinoma.Methods Brucine nanoparticles with block copolymer of carboxylation polyethylene glycol and polylactic acid were manufactured by ultraphonic emulsification.The effect brucine nanoparticles on growth of SMMC-7721 cell line was observed in vitro.The protein and mRNA levels of Fas were measured with Western blotting and FQ-PCR respectively after the brucine nanoparticles were added into cell culture fluid for 72 hours.Results The mean diameter,the carried drug rate and the entrapment rate of brucine nanopaticles was 146±96 nm,4.2％ and 67％,respectively.The growth inhibition of liver cancer cells was enhanced significantly with the increasing drug dose.The IC50 of growth inhibition of 5-FU,brucine and brucine nanoparticles was 16.7 μg/ml,90.3 μg/ml and 164.9 μtg/ml,respectively.There was significant difference among them (P＜0.05).The protein and mRNA expression of Fas in brucine nanoparticles treated SMMC-7721 cells increased significantly compared with that in blank control group(P＜0.05).Conclusion Brucine nanoparticles may potentially be a novel therapeutic drug for hepatocellular carcinoma.
